(Q71059830)
Statements
Phase I dose-escalation trial of gemcitabine and cisplatin for advanced non-small-cell lung cancer: usefulness of mathematic modeling to determine maximum-tolerable dose (English)
F A Shepherd
R Burkes
Y Cormier
M Crump
R Feld
T Strack